| 72 |
X |
X |
|
2020 |
Pol Arch Intern Med(2020) |
Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome?
|
K Ożegowska
|
| 71 |
|
X |
|
2020 |
J Clin Med 9(8):2636(2020) |
Advances in Platelet Function Testing-Light Transmission Aggregometry and Beyond
|
JL Blanc
|
| 69 |
X |
X |
|
2020 |
Pediatr Int (2020) |
A microchip flow-chamber assay screens congenital primary hemostasis disorders
|
Y Nakajima
|
| 67 |
X |
X |
|
2020 |
Kardiol Pol 78(7-8),p667-673(2020) |
New methodological approaches for assessing thrombus formation in cardiovascular disease
|
K Hosokawa
|
| 66 |
|
X |
|
2020 |
J Pediatr S0022-3476(20),p30726-30735(2020) |
Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease
|
N Tsujii
|
| 65 |
|
X |
|
2020 |
Br J Haematol (2020) |
Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System in Comparison to the Platelet Function Analyser in Subjects With Primary Haemostatic Defects
|
J Charpy
|
| 62 |
X |
X |
|
2020 |
Front Vet Sci 7:307(2020) |
A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis
|
T Iwanaga
|
| 60 |
X |
X |
|
2020 |
Circ J 84(6),p975-984(2020) |
Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
|
S Kikuchi
|
| 59 |
|
X |
|
2019 |
Haematologica 235549(2019) |
Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab
|
K Sakai
|
| 58 |
X |
X |
|
2019 |
Int J Hematol 111, p369-377(2020) |
Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system
|
Y Nakajima
|
| 57 |
X |
X |
|
2019 |
J Atheroscler Thromb 27(3),p201-203(2020) |
Monitoring of Antithrombotic Therapy
|
M Yamazaki
|
| 56 |
X |
X |
|
2019 |
Thromb J 17, 17 (2019) |
Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study observational study
|
K Yamamoto
|
| 55 |
X |
X |
|
2019 |
J Atheroscler Thromb 27,p215-225(2020) |
Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease
|
T Mitsuse
|
| 54 |
X |
X |
|
2019 |
Thromb Haemost 119,p1554-1562(2019) |
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
|
K Kaikita
|
| 53 |
X |
X |
|
2019 |
Sci Rep 9:6573(2019) |
Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis
|
MM Piasecka
|
| 52 |
X |
X |
|
2019 |
Circ J 83(6),p1309-1316(2019) |
Impact of Total Antithrombotic Effect on Bleeding Complications in Patients Receiving Multiple Antithrombotic Agents
|
S Ichikawa
|
| 50 |
X |
X |
|
2019 |
Clin Exp Thromb Hemost 5(1),p1-7(2019) |
Effects of Peroxisome Proliferator-Activated Receptor Ligand and Brown Seaweed Based Compound on Megakaryocyte
|
JL Choi
|
| 48 |
|
X |
|
2018 |
J Cardiothorac Vasc Anesth 33(8),p2125-2132(2019) |
Von Willebrand Factor-GP 1b α Interactions in Venoarterial Extracorporeal Membrane Oxygenation Patients
|
M Mazzeffi
|
| 47 |
|
X |
|
2018 |
Alcohol Alcohol 54(1),p13-18(2019) |
Inhibition by Ethanol of Shear Stress-Induced Formation of Platelet Thrombin in Whole Blood
|
K Ekawa
|
| 45 |
|
X |
|
2018 |
Blood 133(7),p633-643(2019) |
Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line
|
K Tozawa
|
